These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 12785294)
1. Cefpodoxime: pharmacokinetics and therapeutic uses. Chugh K; Agrawal S Indian J Pediatr; 2003 Mar; 70(3):227-31. PubMed ID: 12785294 [TBL] [Abstract][Full Text] [Related]
2. Cefpodoxime proxetil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential. Frampton JE; Brogden RN; Langtry HD; Buckley MM Drugs; 1992 Nov; 44(5):889-917. PubMed ID: 1280571 [TBL] [Abstract][Full Text] [Related]
3. Cefpodoxime proxetil. An appraisal of its use in antibacterial cost-containment programmes, as stepdown and abbreviated therapy in respiratory tract infections. Balfour JA; Benfield P Pharmacoeconomics; 1996 Aug; 10(2):164-78. PubMed ID: 10163419 [TBL] [Abstract][Full Text] [Related]
5. Cefpodoxime proxetil: a review of its use in the management of bacterial infections in paediatric patients. Fulton B; Perry CM Paediatr Drugs; 2001; 3(2):137-58. PubMed ID: 11269640 [TBL] [Abstract][Full Text] [Related]
6. Cefpodoxime proxetil in the treatment of lower respiratory tract infections. Geddes AM Drugs; 1991; 42 Suppl 3():34-40. PubMed ID: 1726206 [TBL] [Abstract][Full Text] [Related]
8. [Pharmacokinetic, bacteriological and clinical studies on cefpodoxime proxetil in the field of pediatrics]. Akita H; Sato Y; Iwata S; Sunakawa K Jpn J Antibiot; 1989 Jul; 42(7):1547-60. PubMed ID: 2810729 [TBL] [Abstract][Full Text] [Related]
9. Cefpodoxime - utility in respiratory tract infections and typhoid fever. Aggarwal A; Rath S Indian J Pediatr; 2004 May; 71(5):413-5. PubMed ID: 15163869 [TBL] [Abstract][Full Text] [Related]
10. Cefpodoxime proxetil: dosage, efficacy and tolerance in adults suffering from respiratory tract infections. Safran C J Antimicrob Chemother; 1990 Dec; 26 Suppl E():93-101. PubMed ID: 2292535 [TBL] [Abstract][Full Text] [Related]
11. [RU 51807 (cefpodoxime proxetil). In vitro and in vivo antibacterial activity of a new orally administered active cephalosporin]. Chantot JF; Mauvais P Pathol Biol (Paris); 1991 Jan; 39(1):17-27. PubMed ID: 1901403 [TBL] [Abstract][Full Text] [Related]
12. A review of the pharmacokinetics of cefpodoxime proxetil. Borin MT Drugs; 1991; 42 Suppl 3():13-21. PubMed ID: 1726203 [TBL] [Abstract][Full Text] [Related]
13. Cefpodoxime proxetil--a new oral cephalosporin. Med Lett Drugs Ther; 1992 Nov; 34(884):107-8. PubMed ID: 1435506 [No Abstract] [Full Text] [Related]
14. Cefpodoxime proxetil. Del Beccaro MA Pediatr Ann; 1993 Mar; 22(3):187-92, 195-6. PubMed ID: 8464650 [No Abstract] [Full Text] [Related]
15. Review of clinical experience in the United States with cefpodoxime proxetil in adults with uncomplicated urinary tract infections. Cox CE; Graveline JF; Luongo JM Drugs; 1991; 42 Suppl 3():41-50. PubMed ID: 1726207 [TBL] [Abstract][Full Text] [Related]
16. Clinical experience with cefpodoxime proxetil in acute otitis media. Cohen R Pediatr Infect Dis J; 1995 Apr; 14(4 Suppl):S12-8. PubMed ID: 7792125 [TBL] [Abstract][Full Text] [Related]
17. In vitro activity of cefpodoxime proxetil (U-76,252; CS-807) against Neisseria gonorrhoeae. Schaadt RD; Yagi BH; Zurenko GE Antimicrob Agents Chemother; 1990 Feb; 34(2):371-2. PubMed ID: 2109583 [TBL] [Abstract][Full Text] [Related]
18. Antibacterial activity of oral antibiotics against community-acquired respiratory pathogens from three European countries. Schito GC; Georgopoulos A; Prieto J J Antimicrob Chemother; 2002 Jul; 50 Suppl():7-11. PubMed ID: 12077154 [TBL] [Abstract][Full Text] [Related]
19. [Clinical evaluation of cefpodoxime proxetil on the treatment of bacterial infections]. Li JT; Hou J; Kao L Zhonghua Nei Ke Za Zhi; 1994 Jul; 33(7):440-3. PubMed ID: 7867436 [TBL] [Abstract][Full Text] [Related]
20. [Comparison of pharmacokinetics/pharmacodynamics of cefdinir, cefpodoxime proxetil and cefaclor against common bacteria of community acquired infections]. Xiao YH; Gao L; Li Y; Lü Y; Liu J; Liu Y Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(22):1867-71. PubMed ID: 15631795 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]